BAY 2686013

Last updated
BAY 2686013
BAY2686013 structure.png
Identifiers
  • 2-amino-N-[4-[[3,5-bis(trifluoromethyl)phenyl]methoxy]phenyl]acetamide
CAS Number
PubChem CID
Chemical and physical data
Formula C17H14F6N2O2
Molar mass 392.301 g·mol−1
3D model (JSmol)
  • C1=CC(=CC=C1NC(=O)CN)OCC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F
  • InChI=1S/C17H14F6N2O2/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)9-27-14-3-1-13(2-4-14)25-15(26)8-24/h1-7H,8-9,24H2,(H,25,26)
  • Key:YHGBLECINAKBKX-UHFFFAOYSA-N

BAY 2686013 is a drug used in scientific research which acts as a selective antagonist of the pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and is expected to be useful for characterizing the function of this receptor. [1]

See also

References

  1. ↑ Langer G, Scott J, Lind C, Otto C, Bothe U, Laux-Biehlmann A, Müller J, le Roy B, Irlbacher H, Nowak-Reppel K, Schlüter A, Davenport AJ, Slack M, Bäurle S (September 2023). "Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor". Molecular Pharmacology. 104 (3): 105–114. doi:10.1124/molpharm.122.000662. PMID   37348913.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.